ST Pharm Co.,Ltd. (237690.KQ)

KRW 78200.0

(0.9%)

Inventory Summary of ST Pharm Co.,Ltd.

ST Pharm Co.,Ltd.'s latest annual inventory in 2023 was 120.73 Billion KRW , up 12.18% from previous year.
ST Pharm Co.,Ltd.'s latest quarterly inventory in 2024 Q1 was 133.78 Billion KRW , up 10.8% from previous quarter.
ST Pharm Co.,Ltd. reported annual inventory of 107.62 Billion KRW in 2022, up 33.18% from previous year.
ST Pharm Co.,Ltd. reported annual inventory of 80.8 Billion KRW in 2021, up 77.99% from previous year.
ST Pharm Co.,Ltd. reported quarterly inventory of 133.78 Billion KRW for 2024 Q1, up 10.8% from previous quarter.
ST Pharm Co.,Ltd. reported quarterly inventory of 134.33 Billion KRW for 2023 Q2, up 5.8% from previous quarter.

Annual Inventory Chart of ST Pharm Co.,Ltd. (2023 - 2015)

Historical Annual Inventory of ST Pharm Co.,Ltd. (2023 - 2015)

Year	Inventory	Inventory Growth
2023	120.73 Billion KRW	12.18%
2022	107.62 Billion KRW	33.18%
2021	80.8 Billion KRW	77.99%
2020	45.4 Billion KRW	10.94%
2019	40.92 Billion KRW	0.65%
2018	40.65 Billion KRW	-29.87%
2017	57.97 Billion KRW	-36.55%
2016	91.37 Billion KRW	55.63%
2015	58.71 Billion KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q2	154.71 Billion KRW	15.65%
2024 Q1	133.78 Billion KRW	10.8%
2023 Q2	134.33 Billion KRW	5.8%
2023 Q4	120.73 Billion KRW	-19.07%
2023 FY	120.73 Billion KRW	12.18%
2023 Q1	126.96 Billion KRW	17.97%
2023 Q3	149.18 Billion KRW	11.05%
2022 Q3	118.58 Billion KRW	4.94%
2022 FY	107.62 Billion KRW	33.18%
2022 Q4	107.62 Billion KRW	-9.24%
2022 Q2	113 Billion KRW	16.16%
2022 Q1	97.28 Billion KRW	20.39%
2021 Q4	80.8 Billion KRW	0.35%
2021 Q1	56.52 Billion KRW	24.49%
2021 Q2	69.59 Billion KRW	23.13%
2021 Q3	80.53 Billion KRW	15.72%
2021 FY	80.8 Billion KRW	77.99%
2020 Q1	53.09 Billion KRW	29.75%
2020 FY	45.4 Billion KRW	10.94%
2020 Q4	45.4 Billion KRW	-25.21%
2020 Q3	60.7 Billion KRW	13.53%
2020 Q2	53.46 Billion KRW	0.7%
2019 Q2	49.75 Billion KRW	12.14%
2019 Q3	55.39 Billion KRW	11.33%
2019 Q4	40.92 Billion KRW	-26.12%
2019 Q1	44.36 Billion KRW	9.12%
2019 FY	40.92 Billion KRW	0.65%
2018 Q1	54.55 Billion KRW	-5.9%
2018 FY	40.65 Billion KRW	-29.87%
2018 Q3	47.18 Billion KRW	1.75%
2018 Q2	46.37 Billion KRW	-14.99%
2018 Q4	40.65 Billion KRW	-13.84%
2017 Q2	77.87 Billion KRW	-14.93%
2017 Q1	91.55 Billion KRW	0.2%
2017 Q4	57.97 Billion KRW	-22.19%
2017 FY	57.97 Billion KRW	-36.55%
2017 Q3	74.5 Billion KRW	-4.33%
2016 Q4	91.37 Billion KRW	27.56%
2016 Q2	69.41 Billion KRW	0.0%
2016 Q1	- KRW	-100.0%
2016 Q3	71.63 Billion KRW	3.19%
2016 FY	91.37 Billion KRW	55.63%
2015 FY	58.71 Billion KRW	0.0%
2015 Q4	58.71 Billion KRW	0.0%

Peer Inventory Comparison of ST Pharm Co.,Ltd.

Name	Inventory	Inventory Difference
Sam Chun Dang Pharm. Co., Ltd	35.26 Billion KRW	-242.392%
Hyundai Bioscience Co., Ltd.	2.58 Billion KRW	-4564.976%
ABL Bio Inc.	- KRW	-Infinity%
Cellid, Co., Ltd.	- KRW	-Infinity%